JPRN-UMIN000003796招募中2 期
eoadjuvant Chemotherapy with Oxaliplatin plus Fluorouracil l-Leucovorin or Oxaliplatin plus Capecitabin and MoAb for resectable colorectal liver metastases(CML) from tokai digestive cancer trials group - Neoadjuvant Chemotherapy with Oxaliplatin plus Fluorouracil l-Leucovorin or Oxaliplatin plus Capecitabin and MoAb for resectable colorectal liver metastases (COMET)
Epidemiological and Clinical Research Information Network0 个研究点目标入组 45 人开始时间: 2010年6月22日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1,Serious myelosuppression 2.Serious infection 3,Large quantity of abdominal or pleural effusion 4,cardiovascular disease, complication 5,sensory alteration or paresthesia interfering with function 6,No brain or bone metastasis, active double cancer 7,No hypersensitivity for test drugs 8,Serious pulmonary disease 9,Liver cirrhosis 10,Multiple cancer patient
研究者
相似试验
已完成
2 期
Treatment using Oxaliplatin and S-1 Adjuvant chemotherapy for Stage III gastric cancer trialGastric cancerJPRN-UMIN000025824Department of Surgery, Kochi Medical School75
已完成
不适用
Pre and post operative chemotherapy with oxaliplatin, 5-Fluorouracil (5 FU)/Leucovorin (LV) versus surgery alone in resectable liver metastases from colorectal origiColon, rectumCancerISRCTN55293778Cancer Research UK (CRUK) (UK)363
已完成
不适用
eoadjuvant chemotherapy of S-1/OXaliplatin for locally advanced Gastric cancer PIIgastric cancerJPRN-UMIN000018661Kobe City Medical Center General Hospital40
已完成
1 期
eoadjuvant chemotherapy of S-1/OXaliplatin for locally advanced Gastric cancer PIgastric cancerJPRN-UMIN000015181Kobe City Medical Center General Hospital9
进行中（未招募）
1 期
Phase 2 trial of neo-adjuvant Oxaliplatin and 5-fluorouracil in oesophageal cancer - Oxali/5FU in Oesophageal CancerOperable oesophageal cancerEUCTR2005-001834-34-GBOxford Radcliffe Hospitals NHS Trust